Latest News and Press Releases
Want to stay updated on the latest news?
-
HAMBURG, Germany, June 29, 2009 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (Nasdaq:EVTC) today announced the successful completion of the first Phase I study with its P2X7 receptor antagonist EVT...
-
HAMBURG, Germany, May 12, 2009 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (Nasdaq:EVTC) today reported results and corporate development updates for the first quarter ended March 31,...
-
* Strong addition to Evotec's core business in drug discovery * Acquisition against GBP0.5 million cash in 2009 expected to add approximately GBP1.5 million revenues in 2010 * Additional...
-
HAMBURG, Germany, May 6, 2009 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (Nasdaq:EVTC) will report its financial results for the first quarter of 2009 on Tuesday, May 12, 2009. The Company is...
-
-- Evotec to Concentrate All Proprietary Core Research Programs At Its European operations -- Leveraging World-Class Discovery Alliance Business Infrastructure Will Lead to a Minimum of...
-
HAMBURG, Germany, April 27, 2009 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (Nasdaq:EVTC) announced today that the Supervisory Board proposes at the next Annual General Meeting to be held on June...
-
HAMBURG, Germany, April 14, 2009 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (Nasdaq:EVTC) today announced the results of a Phase II proof-of-concept study investigating the potential of EVT 302, a...
-
HAMBURG, Germany, March 27, 2009 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (Nasdaq:EVTC) today reported financial results for the year ended December 31, 2008. Evotec revenues for the twelve...
-
* Immediate Significant Cost Reductions and Focus on Core R&D Programs * More Assets Will be Made Available for Strategic Partnering * Invest and Grow Discovery Alliances...
-
HAMBURG, Germany, March 25, 2009 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (Nasdaq:EVTC) is going to broadcast its annual analyst and press conference in Frankfurt live on the internet. Dr Werner...